Tesla's (TSLA) "We, Robot" event lacked details and updates on several important fronts, leaving analysts at Morgan Stanley and Oppenheimer disappointed. At the event late Thursday, the electric ...
Company announces updated Phase 1b clinical data on ACTengine® IMA203 targeting PRAME in 28 heavily pretreated metastatic melanoma patients with substantially enhanced maturity compared to the last ...